Related Experiment Video
Updated: Jun 3, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Utilizing Lactic Acid Bacteria to Improve Hyperlipidemia: A Comprehensive Analysis from Gut Microbiota to Metabolic
Changlu Ma1,2, Chen Xu2, Mumin Zheng2
1Department of Food and Bio-Engineering, Beijing Vocational College of Agriculture, Beijing 102442, China.
This study shows the probiotic Lactobacillus casei CAAS36 effectively lowers cholesterol and improves gut health in hyperlipidemic hamsters. It highlights potential for natural management of high cholesterol and related metabolic disorders.
Area of Science:
- Microbiology
- Metabolic Science
- Nutritional Science
Background:
- Hyperlipidemia is a major risk factor for cardiovascular diseases.
- Gut microbiota plays a crucial role in metabolic regulation.
- Probiotics are being investigated for their potential health benefits.
Purpose of the Study:
- To investigate the cholesterol-lowering effects of Lactobacillus casei CAAS36.
- To assess the impact of L. casei CAAS36 on gut microbiota composition and metabolic pathways in hyperlipidemic hamsters.
Main Methods:
- 1H NMR-based metabolomics was used to analyze metabolic profiles.
- 16S rRNA gene sequencing was employed to study gut microbiota composition.
- Hyperlipidemic hamster model was utilized to evaluate the probiotic's efficacy.
Main Results:
- L. casei CAAS36 treatment significantly reduced total cholesterol, LDL-C, and triglycerides, while increasing HDL-C.
- The probiotic altered gut microbiota composition, restoring the Firmicutes/Bacteroidetes balance and increasing propionate producers.
- Key beneficial metabolites, including propionate and succinate, were significantly increased.
Conclusions:
- L. casei CAAS36 demonstrates dual regulatory effects on metabolic profiles and gut microbiota.
- This probiotic shows significant potential for managing hyperlipidemia and other metabolic diseases.
- L. casei CAAS36 could serve as a natural therapeutic agent, reducing reliance on conventional drugs.
Related Concept Videos
Lipid Catabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Digestion
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Formation of Lipopolysaccharides

